Black Diamond Therapeutics (BDTX) Payables (2018 - 2026)
Black Diamond Therapeutics (BDTX) posted Payables of $3.0 million for Q1 2026, up 412.78% on a QoQ basis from $579000.0 in Q4 2025, and up 12.98% year-over-year from $2.6 million in Q1 2025.
Black Diamond Therapeutics (BDTX) Payables (2018 - 2026) Analysis & Trends
Black Diamond Therapeutics' Payables history runs 9 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- Quarterly Payables rose 12.98% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (up 12.98% YoY) and the FY2025 annual result came in at $579000.0, down 85.55% from the prior year.
- Payables was $3.0 million for Q1 2026 at Black Diamond Therapeutics, up from $579000.0 in the prior quarter.
- Across five years, Payables topped out at $5.8 million in Q3 2022 and bottomed at $579000.0 in Q4 2025.
- A 5-year average of $2.1 million and a median of $2.0 million in 2024 frame the typical range for Payables.
- Annual changes were most pronounced in 2023 — Payables plunged 87.95% — and 2024, when it surged 184.01%.
- Black Diamond Therapeutics' Payables stood at $1.9 million in 2022, then grew by 23.81% to $2.3 million in 2023, then soared by 72.42% to $4.0 million in 2024, then tumbled by 85.55% to $579000.0 in 2025, then surged by 412.78% to $3.0 million in 2026.
- Business Quant data shows BDTX's Payables at $3.0 million in Q1 2026, $579000.0 in Q4 2025, and $975000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 10.62 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 8.69 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 423.55 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 80.54 Mn |
| 10 | Black Diamond Therapeutics | 99.59 Mn | -18.67 Mn | - | 2.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.97 Mn |
| Dec 31, 2025 | 579,000.00 |
| Sep 30, 2025 | 975,000.00 |
| Jun 30, 2025 | 771,000.00 |
| Mar 31, 2025 | 2.63 Mn |
| Dec 31, 2024 | 4.01 Mn |
| Sep 30, 2024 | 1.97 Mn |
| Jun 30, 2024 | 763,000.00 |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | 2.32 Mn |
| Sep 30, 2023 | 694,000.00 |
| Jun 30, 2023 | 2.74 Mn |
| Mar 31, 2023 | 3.05 Mn |
| Dec 31, 2022 | 1.88 Mn |
| Sep 30, 2022 | 5.76 Mn |
| Jun 30, 2022 | 2.22 Mn |
| Mar 31, 2022 | 1.88 Mn |
| Dec 31, 2021 | 4.11 Mn |
| Sep 30, 2021 | 4.86 Mn |
| Jun 30, 2021 | 5.03 Mn |